title: Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
authors.affiliation: Division of Digestive Diseases and The Emory Transplant Center, Emory University Hospital, Atlanta, Georgia, USA.
authors.forename: Anjana A
authors.initials: AA
authors.lastname: Pillai
authors.affiliation: Department of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
authors.forename: Frank A
authors.initials: FA
authors.lastname: Anania
authors.affiliation: Center for Hepatitis C, Atlanta Medical Center, Emory School of Medicine, Augusta, Georgia, USA.|Medical College of Georgia, Augusta, Georgia, USA.
authors.forename: Brian L
authors.initials: BL
authors.lastname: Pearlman
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069616:Simeprevir / Q000627:therapeutic use; D000069474:Sofosbuvir / Q000627:therapeutic use; D000068698:Tenofovir / Q000627:therapeutic use; D019562:Viral Load; D014775:Virus Activation
chemical_list: D000998:Antiviral Agents; C413685:entecavir; D006147:Guanine; D000068698:Tenofovir; D000069616:Simeprevir; D000069474:Sofosbuvir